Evidence map›Paper›PMID 39236073›Full record

ArticlePLoS computational biology2024

Surveillance strategies for the detection of new pathogen variants across epidemiological contexts.

Kirstin I Oliveira Roster, Stephen M Kissler, Enoma Omoregie, Jade C Wang, Helly Amin, Steve Di Lonardo, Scott Hughes, Yonatan H Grad

Abstract read
In one paragraph

Article in PLoS computational biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kirstin I Oliveira RosterDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.ORCID 0000-0003-3468-2014
Stephen M KisslerDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Enoma OmoregieNew York City Department of Health and Mental Hygiene, New York City, New York, United States of America.
Jade C WangNew York City Department of Health and Mental Hygiene, New York City, New York, United States of America.
Helly AminNew York City Department of Health and Mental Hygiene, New York City, New York, United States of America.
Steve Di LonardoNew York City Department of Health and Mental Hygiene, New York City, New York, United States of America.
Scott HughesNew York City Department of Health and Mental Hygiene, New York City, New York, United States of America.
Yonatan H GradDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.ORCID 0000-0001-5646-1314

Funding

CDC HHS 200-2016-91779CDC HHS 6NU50CK000517-01-07São Paulo Research Foundation (FAPESP) 2021/11608-6
6 · The paper itself

Abstract

Surveillance systems that monitor pathogen genome sequences are critical for rapidly detecting the introduction and emergence of pathogen variants. To evaluate how interactions between surveillance capacity, variant properties, and the epidemiological context influence the timeliness of pathogen variant detection, we developed a geographically explicit stochastic compartmental model to simulate the transmission of a novel SARS-CoV-2 variant in New York City. We measured the impact of (1) testing and sequencing volume, (2) geographic targeting of testing, (3) the timing and location of variant emergence, and (4) the relative variant transmissibility on detection speed and on the undetected disease burden. Improvements in detection times and reduction of undetected infections were driven primarily by increases in the number of sequenced samples. The relative transmissibility of the new variant and the epidemic context of variant emergence also influenced detection times, showing that individual surveillance strategies can result in a wide range of detection outcomes, depending on the underlying dynamics of the circulating variants. These findings help contextualize the design, interpretation, and trade-offs of genomic surveillance strategies of pandemic respiratory pathogens.

Indexed as

COVID-19SARS-CoV-2Computational BiologyGenome, ViralHumansNew York CityPandemics

Identifiers

PMID39236073
PMCPMC11407617

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.